Since 1986 when we first opened, Boston IVF has conducted ground-breaking research that has contributed to vast improvements in assisted reproductive technologies and fertility treatment. Patients at Boston IVF benefit from working with the experts who conducted these studies; when appropriate, patients are invited to participate in research studies as well.
The following studies are currently enrolling:
ANTI-MULLERIAN HORMONE (AMH) STUDY
The purpose of the study is to evaluate a new lab test for Anti-Mullerian Hormone (AMH). This is a blood test that may give us information about your fertility. Participants will be asked to have an extra tube of blood drawn on one occasion and share information from their medical record about their health histpry. This will include the results of your ultrasound.
Eligible participants are:
• Women seeking fertility treatment/assessment at Boston IVF
• Between the ages of 21-44
Qualified participants will be compensated $50 for their involvement in this study.
If you are interested in learning more about this study and whether you may be eligible to participate, please contact Study Coordinator Kristin Rooney at 781.434.6470.